thisdrug what a medicine's name tells you

WHO naming stem · suffix · 18 listed names

-parin

heparin derivatives including low molecular mass heparins

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -parin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -parin. So the letters parin sit at the end of the name (…parin).

All 18 names WHO lists under -parin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. adomiparin sodium
  2. ardeparin sodium
  3. bemiparin sodium
  4. certoparin sodium
  5. dalteparin sodium
  6. deligoparin sodium
  7. enoxaparin sodium
  8. fondaparin sodium
  9. heparin sodium
  10. livaraparin calcium
  11. minolteparin sodium
  12. nadroparin calcium
  13. parnaparin sodium
  14. reviparin sodium
  15. semuloparin sodium
  16. sevuparin sodium
  17. tafoxiparin sodium
  18. tinzaparin sodium

Decode another name

Decoded

heparin sodium

Listed INNCarries 2 WHO stems, most specific first: -parin …

  • -parininside the nameWHO lists it hereWHO definition: heparin derivatives including low molecular mass heparins
  • -iumend of the nameWHO definition: quaternary ammonium compounds

“heparin sodium” is an INN that WHO lists under -parin in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -parin (Part II B) and the 18 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.